6:12 PM
 | 
Dec 10, 2012
 |  BC Extra  |  Financial News

Zogenix falls after FDA panel rebuffs Zohydro ER

Zogenix Inc. (NASDAQ:ZGNX) fell $1.20 (51%) to $1.16 on Monday after an FDA panel voted 11-2 with one abstention on Friday against...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >